Replies to post #91 on Nobilis Health Corp (NRTSF)

[1center]

$HLTH will have to raise guidance again analyst....
Gibson believes Nobilis will generate EBITDA of $52.8-million on revenue of $281.1-million in fiscal 2016. He expects these numbers will improve to EBITDA of $67.6-million on a topline of 343.6-million the following year.

http://www.cantechletter.com/2017/01/nobilis-health-acquisition-hamilton-vein-center-gets-thumbs-pi/

https://finance.yahoo.com/news/nobilis-acquire-texas-based-vascular-100000645.html

Previous acquisition resulted in
Updated Full Year 2016 Guidance
The Company raised its full year 2016 guidance for total revenues and adjusted EBITDA1 to reflect the closing of the acquisition of AVVC and ACMIS. Full year 2016 total revenues are now expected to be $281 million, up from $275 million. Full year Adjusted EBITDA1 is now expected to be $53 million, up from $51 million

http://investors.nobilishealth.com/investors/press-releases/press-release-details/2016/Nobilis-Health-Corp-Announces-Completion-of-Acquisition-of-Arizona-Vascular-Clinics--New-825-Million-Credit-Facility/default.aspx